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Introduction {#sec1}
============

Feeding involves a complex series of actions that an animal must undertake in order to procure nutrients in a timely and safe manner. In the wild, feeding is often associated with exploration of novel and potentially dangerous environments. As a result, the systems controlling feeding behavior have evolved under a requirement for swift selection of situationally appropriate behaviors and accurate metabolic tuning. This involves integration of internal homeostatic signals, external environmental stressors, motivational drives, and learned associations to consolidate conflicts between risk mitigation and the requirement to feed. Consistent with these observations, the neurocircuitry and whole-body physiological processes underlying energy homeostasis have substantial functional overlap with the systems controlling responses to stressful situations ([@bib35], [@bib36]). For example, arcuate nucleus agouti-related peptide (AgRP), lateral hypothalamic, and amygdalar neurons have important roles in the incorporation of various emotional aspects into the regulation of feeding ([@bib35]). In experimental models and humans, both disordered eating behavior and obesity have a significant association with stress-related behavioral changes, such as anxiety and depression ([@bib1], [@bib13], [@bib14], [@bib16], [@bib34]).

The ventromedial hypothalamus (VMH) is a key brain region involved in the control of feeding, metabolism, and the manifestation of stress and anxiety-related behaviors. Lesioning and electrical stimulation studies implicate the VMH in the regulation of feeding, body weight, and defensive behaviors ([@bib20]), and a role in the link between appetitive and affective responses has also been suggested ([@bib15]). Recent studies manipulating nutrient- and hormone-sensing-signaling pathways in steroidogenic factor 1 (SF1) neurons have confirmed the role of the VMH in the regulation of body weight and metabolism. However, somewhat surprisingly, the studies have in general not detected effects on acute food intake ([@bib8], [@bib10], [@bib12], [@bib19], [@bib21], [@bib28], [@bib39], [@bib40]). Pharmacogenetic and optogenetic manipulations of SF1 neurons have shown that these cells regulate defensive social states ([@bib29], [@bib30]) and profound escape behaviors ([@bib22], [@bib37]), and a recent study has shown that the activation of SF1 neurons can suppress acute feeding but through indeterminate mechanisms ([@bib11]). Despite these observations, the precise relationships among SF1 neuronal activity, acute feeding regulation, and other behaviors associated with the VMH function remain unclear.

Here we find that SF1 neurons alter feeding via direct changes in appetite and by altering locomotion, exploration, anxiety, valence, memory, and risk-taking. We demonstrate an SF1 neuron firing frequency-dependent switch between feeding and anxiety-related behavior that is also sensitive to energy stores, with low intrinsic SF1 activity being permissive for feeding while increased activity occludes food intake. Thus, we identify a key integrative role for SF1 neurons in the regulation of feeding and associated behavioral states.

Results {#sec2}
=======

Firing Pattern Characteristics and Behavioral Outcomes of Optogenetic Activation of SF1 Neurons Depend on Stimulation Frequency {#sec2.1}
-------------------------------------------------------------------------------------------------------------------------------

To activate VMH SF1 neurons, we injected adeno-associated virus (AAV) particles containing a Cre-dependent, mCherry-fused channelrhodopsin (ChR2) virus (AAV1-DIO-ChR2-mCherry) into the VMH of SF1-Cre mice to produce SF1-ChR2 animals. We used Cre-negative littermates and/or AAV1-DIO-EYFP-injected SF1-Cre mice as controls. mCherry or EYFP was expressed in the VMH, with more than 80% of SF1 neurons expressing ChR2 ([Figure S1](#mmc1){ref-type="supplementary-material"}A; data not shown). In acute VMH slice patch recordings, tonic 1-ms, 2-Hz photo-stimulation produced spiking with 100% fidelity, preserved some endogenous action potentials, and modestly increased firing frequency ([Figure S1](#mmc1){ref-type="supplementary-material"}B; data not shown). *In vivo*, this firing frequency was associated with increased c-*fos* expression in the VMH, indicating neuronal activation ([Figures S1](#mmc1){ref-type="supplementary-material"}C and S1D). However, with photo-stimulation frequencies of 5 Hz or higher in slice preparations, the endogenous action potential firing pattern was occluded and replaced by an optogenetically driven firing pattern ([Figure S1](#mmc1){ref-type="supplementary-material"}B). The c-*fos* expression was significantly higher with *in vivo* 10-Hz stimulation than in control or 2-Hz-stimulated SF1-ChR2 animals ([Figures S1](#mmc1){ref-type="supplementary-material"}C and S1D). Thus, higher-frequency optogenetic stimulation (\>5 Hz) overrode intrinsic firing patterns, and it resulted in significantly increased neuronal recruitment *in vivo*.

High-frequency optogenetic stimulation (\>20 Hz) of SF1 neurons causes profound defensive responses, including freezing and escape attempts. We observed these behaviors at similar stimulation frequencies ([Figure S1](#mmc1){ref-type="supplementary-material"}E; data not shown). However, steady-state SF1 firing frequency in *ex vivo* slice electrophysiology studies ranges between 3.5 and 6.2 Hz ([@bib18], [@bib21]), consistent with our observations (6.2 ± 0.9 Hz; [Figure S1](#mmc1){ref-type="supplementary-material"}F). Nevertheless, brief high-frequency bursts of spiking could be observed \>20 Hz. This action potential firing pattern was also seen during *in vivo* recordings of VMH neurons, which had a steady-state firing frequency of 3.5 ± 0.9 ([Figure S1](#mmc1){ref-type="supplementary-material"}F). Although high-frequency bursts of SF1 neuronal activity may underlie a particular behavioral response (e.g., escape from imminent predator threat), we reasoned that the frequencies typically used to date in optogenetic analyses of SF1 neuron control of behavior may not reflect the physiological role of this neuronal population during non-threatening conditions. Therefore, we examined the behavioral consequences of optogenetically altering SF1 neuronal activity across a range of firing frequencies seen under steady-state conditions. In a real-time place avoidance (RTPA) assay, we confirmed that high-frequency (20-Hz) optogenetic stimulation of SF1 neurons was aversive, with mice avoiding the stimulation chamber ([Figures 1](#fig1){ref-type="fig"}A and 1B). In contrast, low-frequency stimulation of 2 Hz was not aversive, as mice spent equal amounts of time in each chamber ([Figure 1](#fig1){ref-type="fig"}C).Figure 1SF1 Neurons Display Optogenetic Stimulation Frequency-Dependent Divergence of Defensive and Feeding Behaviors(A) Representative movement traces in 20-Hz real-time place aversion (RTPA) assay.(B) Time spent in stimulation chamber in 20-Hz RTPA assay.(C) Same as in (B), but with 2-Hz stimulation.(D) Time spent in the stimulation chamber during the dynamic frequency RTPA assay (dfRTPA).(E) Similar to (D), but conducted in successive alley (SA) arena, with alley 1 as the designated stimulation chamber.(F) Locomotion in square open field during 1 hr of continuous 2- or 5-Hz optogenetic stimulation.(G) Fasted food intake during 2-Hz optogenetic stimulation.(H) Depiction of home cage used in (I)--(K).(I) Locomotion during 5-hr-long, 2-Hz optogenetic stimulation.(J) Time spent in shelter area.(K) Time spent in feeding area.Data are expressed as mean values ± SEM. 2-way ANOVA, repeated-measures (RM), followed by Sidak post hoc tests were performed on (B)--(G), and for (I)--(K) a paired t test was used (^∗^p \< 0.05, ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.001, and ^∗∗∗∗^p \< 0.0001). See also [Figure S1](#mmc1){ref-type="supplementary-material"}.

To address the behavioral outcomes of different stimulation frequencies, we used a 2-chamber dynamic frequency RTPA (dfRTPA) assay, exposing mice to varying optogenetic frequencies in the designated stimulation chamber. The 2-Hz optogenetic stimulation started 5 min after the initial exploration, and stimulation frequency was increased by 0.5 Hz every 5 min to a maximum of 6 Hz. At low frequencies, mice showed no preference for either chamber, but, at frequencies of 4 Hz or higher, a significant aversion to the stimulated chamber was observed, and avoidance increased linearly with stimulation frequency ([Figure 1](#fig1){ref-type="fig"}D).

To determine if optogenetic stimulation-induced avoidance overcomes a pre-existing place preference, we used the dfRTPA protocol in a successive alley (SA) apparatus. Mice were only exposed to the optogenetic stimulation when they were in the preferred safe zone (alley 1). Low-frequency stimulation did not affect place preference, but increasing stimulation frequency resulted in a linear increase in avoidance of the preferred enclosed dark area of alley 1 ([Figure 1](#fig1){ref-type="fig"}E). Therefore, we observed a stimulation frequency threshold in SF1 neurons, where frequencies below 4 Hz were not significantly aversive, while higher frequencies induced active avoidance overcoming pre-existing place preference.

In the RTPA studies, mice terminated optogenetic stimulation by leaving the stimulation chamber. To test whether a more sustained low-frequency stimulation caused changes in locomotion, we used a square open field arena and exposed mice to either 2- or 5-Hz stimulation for 1 hr. Prolonged stimulation at 5 Hz, but not at 2 Hz, significantly increased locomotion ([Figure 1](#fig1){ref-type="fig"}F).

Low-Frequency Optogenetic Stimulation of SF1 Neurons Suppresses Feeding in the Absence of Detectable Anxiety-Associated Behavior {#sec2.2}
--------------------------------------------------------------------------------------------------------------------------------

The absence of behavioral changes with 2-Hz frequency stimulation of SF1 neurons prompted us to examine feeding at this frequency. The 2-Hz stimulation over a 5-hr period significantly suppressed feeding after a fast ([Figure 1](#fig1){ref-type="fig"}G), while virus expression or light administration alone had no effect. Cumulative 24-hr food consumption was not different between the groups, indicating reversibility of the suppressive effects upon feeding ([Figure S1](#mmc1){ref-type="supplementary-material"}G). During an identical stimulation protocol, mice filmed in a home cage environment ([Figure 1](#fig1){ref-type="fig"}H) showed unaltered velocity and time spent in the shelter area, but they spent significantly less time in the feeding zone, suggesting reduced appetitive behavior ([Figures 1](#fig1){ref-type="fig"}I--1K). To exclude low-level stress as measured by autonomic activation as a cause of suppressed feeding, we measured brown adipose tissue temperature and heart rate (HR). While these were unaltered with 2-Hz optogenetic stimulation, 5-Hz stimulation increased temperature but lowered HR ([Figures S1](#mmc1){ref-type="supplementary-material"}H and S1I). In summary, 2-Hz optogenetic stimulation of SF1 neurons activated this population and suppressed feeding, without affecting locomotion, avoidance, or autonomic activity. In contrast, optogenetic firing frequencies of 4 Hz and above resulted in increased avoidance-related and defensive behaviors.

Pharmacogenetic Modulation Results in Changes in the Activity of SF1 Neurons {#sec2.3}
----------------------------------------------------------------------------

To explore the effects of altering SF1 neuron activity under potentially more physiological firing patterns, we used hM3Dq and hM4Di designer receptors exclusively activated by designer drugs (DREADDs) to excite or inhibit SF1 neurons, respectively. Transduction efficiencies of greater than 80% were observed with both viruses ([Figure S2](#mmc1){ref-type="supplementary-material"}A; data not shown). *Ex vivo* electrophysiology showed that SF1-hM3Dq neurons were reversibly depolarized upon brief application of clozapine-N-oxide (CNO) ([Figures 2](#fig2){ref-type="fig"}A and 2B), while SF1-hM4Di neurons were reversibly hyperpolarized and silenced ([Figures 2](#fig2){ref-type="fig"}A and 2C). *In vivo* VMH neuron spiking frequency was increased in SF1-hM3Dq mice ([Figures 2](#fig2){ref-type="fig"}D, 2F--2H, and [S2](#mmc1){ref-type="supplementary-material"}B) and reduced in SF1-hM4Di animals after CNO injection ([Figures 2](#fig2){ref-type="fig"}E--2H). While pharmacogenetically induced changes in the steady-state firing frequency were modest (\<2 Hz) compared to optogenetic stimulation, intrinsic firing patterns were preserved and CNO administration increased the expression of c-*fos* in SF1-hM3Dq animals, indicating *in vivo* activation ([Figures S2](#mmc1){ref-type="supplementary-material"}C and S2D).Figure 2Effects of hM3Dq and hM4Di on SF1 Neuron Electrophysiology(A) Representative trace of slice electrophysiology in SF1-hM3Dq and SF1-hM4Di neurons.(B and C) CNO induced changes in resting membrane potential in SF1-hM3Dq (B) and SF1-hM4Di (C) neurons *ex vivo* (n = 5).(D and E) Representative, 20-s-bin histograms of a VMH neuron firing frequency in SF1-hM3Dq (D) and SF1-hM4Di (E) mice during *in vivo* electrophysiology recordings.(F) Changes in average firing frequency during *in vivo* recordings.(G) Changes in peak firing frequency during the experiment in (F).(H) *Z* score representation of the changes to the firing frequency during the experiment in (F).Data are expressed as mean values ± SEM. A paired t test was used for (B) and (C), and 1-sample t tests were used for (F) and (G) (^∗^p \< 0.05). See also [Figure S2](#mmc1){ref-type="supplementary-material"}.

Acute DREADD-Mediated Activation or Inhibition of SF1 Neuronal Activity Regulates Feeding, and Chronic Modulation Alters Fat Mass {#sec2.4}
---------------------------------------------------------------------------------------------------------------------------------

The activation of SF1 neurons in fasted SF1-hM3Dq mice suppressed feeding in both female and male mice ([Figures 3](#fig3){ref-type="fig"}A and 3B). In contrast, inhibition of SF1 neurons in SF1-hM4Di mice increased cumulative food intake in *ad libitum*-fed mice of both sexes ([Figures 3](#fig3){ref-type="fig"}C and 3D). Control virus expression or CNO did not alter feeding (data not shown). Under freely feeding conditions, SF1-hM3Dq mice ate significantly less, while SF1-hM4Di mice consumed more food compared to controls ([Figure 3](#fig3){ref-type="fig"}E), and this was associated with consistent changes in the number of feeding bouts and the time spent feeding ([Figures S3](#mmc1){ref-type="supplementary-material"}A and S3B). In SF1-hM3Dq mice, we observed none of the dramatic acute escape or defensive behaviors seen with high-frequency optogenetic activation of SF1 neurons.Figure 3Pharmacogenetic Manipulation of SF1 Neuronal Activity Influences Acute Feeding and Sub-chronic Adiposity(A and B) Fasted food intake after CNO administration in female (A) and male (B) SF1-hM3Dq mice.(C and D) *Ad libitum* feeding in female (C) and male (D) SF1-hM4Di mice after CNO administration.(E) Cumulative food intake in the BioDAQ automated feeding system.(F and G) Changes in female (F) and male (G) whole-body adipose mass after 3 weeks of continuous CNO administration via the drinking water.Data are expressed as mean values ± SEM. 2-way ANOVA, RM, followed by Sidak post hoc tests were used for analysis (^∗^p \< 0.05, ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.001, and ^∗∗∗∗^p \< 0.0001). See also [Figure S3](#mmc1){ref-type="supplementary-material"}.

Next, we administered CNO continuously for 3 weeks in the drinking water (50 mg/L), and we measured body composition weekly. Whole-body fat was unaltered in the control animals of either gender, but in both sexes SF1-hM3Dq animals lost while SF1-hM4Di mice gained significant fat mass ([Figures 3](#fig3){ref-type="fig"}F and 3G). Taken together, these observations show that acute or chronic modulation of SF1 neuronal activity has effects on feeding and adiposity.

SF1 Neurons Regulate Affective States that Impact on Feeding Behavior and Appetite {#sec2.5}
----------------------------------------------------------------------------------

Next, we systematically probed the potential role of SF1 neurons to influence both the homeostatic and emotional/affective systems that regulate feeding ([Figure 4](#fig4){ref-type="fig"}A). In a circular open field (COF) task to assess locomotion as a measure of exploratory behavior, 30 min following CNO administration the SF1-hM3Dq mice had decreased activity, while SF1-hM4Di mice moved more than their respective controls ([Figures 4](#fig4){ref-type="fig"}B and 4C). These differences did not persist at 5 hr after CNO injection. We then assessed CNO effects on locomotion and exploration in the presence of food by measuring horizontal and vertical movement in a home cage environment. SF1-hM3Dq mice displayed reduced locomotion and rearing ([Figures 4](#fig4){ref-type="fig"}D and 4E), a measure of diversive exploration, while inhibition of SF1 neurons in SF1-hM4Di mice led to significant increases in both measures of exploratory behavior ([Figures 4](#fig4){ref-type="fig"}D and 4E). Modulation of SF1 neuronal activity, therefore, altered locomotion and exploration, behaviors relevant to food acquisition, in both novel and familiar environments.Figure 4SF1 Neurons Regulate Appetite and Associated Affective States that Impact on Feeding(A) Model of the interplay between homeostatic and affective pathways that influence feeding.(B and C) Locomotion of SF1-hM3Dq (B) and SF1-hM4Di (C) mice in circular open field (COF) 30 min and 5 hr after CNO administration.(D) Moving average (8 time points) of horizontal infrared beam breaks in a home cage environment.(E) Similar to (D), but vertical beam breaks were assessed.(F and G) Time spent by SF1-hM3Dq (F) and SF1-hM4Di (G) mice in the anxiogenic open areas in the elevated zero maze (EZM) task 30 min and 5 hr after CNO administration.(H and I) Time spent in anxiogenic light area of the light/dark arena (LD) by SF1-hM3Dq (H) and SF1-hM4Di (I) mice.(J) Depiction of the behavioral task used in (K)--(O).(K) Area subdivision of the task in (J) and place preference heatmaps of CNO-injected, *ad libitum*-fed animals.(L--O) Velocity (L), time spent in the illuminated center area (M), food intake (N), and time spent near food or non-edible object (O) during the experiment shown in (K).1-way ANOVA with Sidak post hoc was used to analyze (L)--(N), and 2-way ANOVA, RM, Sidak tests were performed on the remaining panel (^∗^p \< 0.05, ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.001, and ^∗∗∗∗^p \< 0.0001). See also [Figure S4](#mmc1){ref-type="supplementary-material"}.

Next, we determined the effects of altering SF1 activity upon behavior in novel anxiogenic environments. At 30 min after CNO administration, exploration of the anxiogenic areas by SF1-hM3Dq animals was significantly reduced in the elevated zero maze (EZM) assay ([Figure 4](#fig4){ref-type="fig"}F), but it was not statistically different from controls in the light/dark (LD; [Figure 4](#fig4){ref-type="fig"}H), elevated plus maze (EPM; [Figure S4](#mmc1){ref-type="supplementary-material"}A), or SA ([Figures S4](#mmc1){ref-type="supplementary-material"}B and S4C) tasks suggesting a mild anxiogenic phenotype. In contrast, the inhibition of SF1 neurons in SF1-hM4Di mice was highly anxiolytic, as these animals had significantly increased exploration of the anxiogenic areas of the EZM ([Figure 4](#fig4){ref-type="fig"}G), LD ([Figure 4](#fig4){ref-type="fig"}I), EPM ([Figure S4](#mmc1){ref-type="supplementary-material"}A), and SA ([Figure S4](#mmc1){ref-type="supplementary-material"}D). Furthermore, SF1-hM3Dq and SF1-hM4Di mice displayed alterations in locomotion with the same directionality and kinetics as seen for the changes in exploration of the open arm in the EZM assay ([Figures S4](#mmc1){ref-type="supplementary-material"}E and S4F).

To assess if SF1 neuronal activity regulates valence and memory, animals were tested for conditioned place preference (CPP) after undergoing a 4-day conditioning protocol. The activation of SF1 neurons did not alter CPP ([Figure S4](#mmc1){ref-type="supplementary-material"}G). In contrast, SF1-hM4Di mice displayed a significant preference for the CNO treatment chamber ([Figure S4](#mmc1){ref-type="supplementary-material"}H). Thus, inhibition of SF1 neurons may produce positive valence and memory formation to the associated cues.

Next, we adapted a square open field arena to simultaneously assess the competing drives of appetite and avoidance. Testing took place in a dimly lit room, while the central region of the arena was illuminated by a bright overhead light ([Figure 4](#fig4){ref-type="fig"}J). Two pots were placed in the central illuminated area, one containing a pellet of chow and the other a similar sized non-edible object ([Figure 4](#fig4){ref-type="fig"}K). *Ad libitum*-fed mice were tested and received CNO 30 min before the task. SF1-hM3Dq mice had reduced locomotion ([Figure 4](#fig4){ref-type="fig"}L), exploration of the central area of the arena ([Figure 4](#fig4){ref-type="fig"}M), and food intake ([Figure 4](#fig4){ref-type="fig"}N), while SF1-hM4Di mice displayed the opposite effects. Furthermore, while control and hM3Dq mice spent equivalent amounts of time at the empty pot and the food pot, hM4Di mice spent increased time at the food pot, suggesting an increase in appetite ([Figures 4](#fig4){ref-type="fig"}K and 4O). Importantly, no gender-specific differences were detected for behaviors assessing affective states.

Inhibition of SF1 Neurons Facilitates the Extinction of Negative Conditioning during Feeding and Dampens Innate Odor-Induced Fear Avoidance of Food {#sec2.6}
---------------------------------------------------------------------------------------------------------------------------------------------------

Next, we determined the role of SF1 neuron activity on risk-taking behavior for food during either negative conditioning or exposure to an olfactory innate fear-inducing cue. In a task based on fear conditioning, naive, overnight-fasted animals were able to choose between three locations: an area with a food pot, a central insulated safety area, and an area with a non-edible object ([Figure 5](#fig5){ref-type="fig"}A). The test lasted for 40 min, with mild (0.4 mA) electric shocks delivered between 10:00 and 19:59 min. Mice could avoid the shocks by staying in the central area ([Figure 5](#fig5){ref-type="fig"}B). Throughout the test, control and SF1-hM4Di mice preferred the food area to the non-edible object area, but this was absent in the SF1-hM3Dq mice ([Figure 5](#fig5){ref-type="fig"}C). During the negative-conditioning phase, all three groups avoided the metal-grid area, spending more time in the safety area ([Figure 5](#fig5){ref-type="fig"}D). Upon discontinuation of the shocks, the inhibition of SF1 neurons facilitated extinction of negative conditioning, as the SF1-hM4Di mice spent less time in the safety zone compared to the control group and to the conditioning phase. Control animals showed a trend toward reduced time in the safety zone during the extinction period, but the SF1-hM3Dq mice did not display any signs of punishment extinction. Similar trends were observed when the food zone was considered ([Figure S5](#mmc1){ref-type="supplementary-material"}A). Together these results suggest that SF1 neurons can regulate the extinction of short-term negative conditioning during feeding.Figure 5SF1 Neurons Regulate the Balance between Food Seeking and Avoidance of Negative Conditioning or TMT(A) Depiction of the negative feeding-conditioning assay.(B) Time spent heatmaps in 10-min bins.(C) Time spent in the food and non-edible object areas during the experiment in (B).(D) Time spent in the safe zone per 10-min bins from the experiment in (B).(E) Illustration of food-seeking and innate fear-inducing olfactory cue (TMT) avoidance behavioral task.(F) Time spent at pots with combinations of food (F± ) and TMT smell (S± ) or all of the pots together.(G) Food intake from F+S+ pot.Data are expressed as mean values ± SEM. 1-way ANOVA with Sidak post hoc test was used for (G) and for different conditions in (F), while 2-way, RM, and Sidak were performed for (C) and (D) (^∗^p \< 0.05, ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.001, and ^∗∗∗∗^p \< 0.0001). See also [Figure S5](#mmc1){ref-type="supplementary-material"}.

To examine whether SF1 neuron activity alters food seeking and feeding under olfactory avoidance-inducing conditions, we designed an assay using the conflicting motivation of the appetitive drive toward food and the avoidance of the innate fear-inducing cue, TMT (2,3,5-Trimethyl-3-trimethylthiazole; [Figure 5](#fig5){ref-type="fig"}E). The arena consisted of four chambers, each containing a pot. Two pots were scented with TMT (S+) and two were non-scented (S−), and, of these, one scented and one non-scented pot also contained food (F+; [Figure S5](#mmc1){ref-type="supplementary-material"}B). Modulation of SF1 neurons had effects on the overall investigation of the pots ([Figure S5](#mmc1){ref-type="supplementary-material"}B), with SF1-hM3Dq mice interacting less and SF1-hM4Di interacting more than the control animals ([Figure 5](#fig5){ref-type="fig"}F). Considering each of the pots separately, time spent at the non-scented, food containing pot (F+S--) was significantly increased in hM4Di and decreased in hM3Dq groups compared to controls ([Figure 5](#fig5){ref-type="fig"}F), while SF1-hM4Di mice also consumed significantly more food from this pot than the controls ([Figure S5](#mmc1){ref-type="supplementary-material"}C). Importantly, SF1-hM4Di mice spent significantly more time at, and consumed more food from, the food-containing, TMT-scented pot (F+S+; [Figures 5](#fig5){ref-type="fig"}F and 5G) compared to controls, suggesting that the inhibition of SF1 neurons enabled SF1-hM4Di animals to partially overcome TMT avoidance when seeking food. However, the opposite effect in the SF1-hM3Dq mice was not significant ([Figures 5](#fig5){ref-type="fig"}F and 5G). No differences for the interaction with the TMT-smelling, food-lacking pot (F−S+) were detected for either of the experimental groups ([Figure 5](#fig5){ref-type="fig"}F), suggesting that SF1 neurons do not regulate avoidance of TMT in the absence of food. Lastly, exploration of the empty, unscented pot (F−S−) was not different between control and hM4Di groups, but it was reduced in SF1-hM3Dq mice ([Figure 5](#fig5){ref-type="fig"}F), demonstrating decreased motivation for exploration and interaction. Modulation of SF1 neurons did not affect the relative place preference between the different pots, except for the F−S− pot ([Figure S5](#mmc1){ref-type="supplementary-material"}D). Therefore, even under potentially adverse environmental conditions that suppressed food intake, the inhibition of SF1 neurons led to significantly attenuated avoidance of the TMT-scented food pot and increased food consumption from this source. These findings suggest that SF1 neuron activity can shift the balance of the competition between food seeking and avoidance of innate fear cues but potentially via alterations in explorative behavior and appetite rather than the avoidance of TMT per se.

Nutrient Deprivation Blunts Avoidance Elicited by Optogenetic Activation of SF1 Neurons {#sec2.7}
---------------------------------------------------------------------------------------

SF1 neurons are sensitive to feeding state and metabolic signals, such as leptin, insulin, and glucose ([@bib7], [@bib8], [@bib21], [@bib33]). We explored whether nutrient status influenced escape or defensive behaviors, reasoning that animals in a state of negative energy balance might be more resistant to the anxiogenic effects of SF1 activation. In the two-chamber dfRTPA assay ([Figures 1](#fig1){ref-type="fig"}E and [S6](#mmc1){ref-type="supplementary-material"}A), fasting significantly blunted the avoidance caused by optogenetic stimulation of SF1 neurons ([Figure 6](#fig6){ref-type="fig"}A). With food added to the stimulation chamber to provide a motivational goal to enter the chamber ([Figure 6](#fig6){ref-type="fig"}B), there were significant effects of adiposity upon the ability of SF1 activation to drive avoidance behavior ([Figure 6](#fig6){ref-type="fig"}C). In the fasted state, calorie-restricted mice ([Figure S6](#mmc1){ref-type="supplementary-material"}B) were less sensitive, while high-fat diet (HFD)-fed animals were more sensitive ([Figure S6](#mmc1){ref-type="supplementary-material"}D) to the stimulation-induced avoidance of the food chamber than the chow-fed mice ([Figure S6](#mmc1){ref-type="supplementary-material"}C). These findings suggest that SF1 neurons, or the neurocircuitry engaged by them, are sensitive to nutritional state and, when the need for nutrients is increased, the ability of SF1 neurons to induce a feeding-suppressing affective behavioral state is blunted.Figure 6Nutrient and Energy Deficiency Blunts SF1 Neuron Stimulation-Induced Avoidance, while Activity Levels Encode Stress and Feeding States(A) Avoidance of the stimulation chamber under a dfRTPA protocol during a fed-fasted crossover study in SF1-ChR2 animals, normalized to the respective controls.(B) Illustration of appetitive dfRTPA task, designed to test the impact of nutrient deprivation on SF1-stimulation-induced avoidance in the presence of food.(C) Avoidance of stimulation chamber in overnight-fasted calorie-restricted (CR), chow-fed (chow/fasted) and HFD-fed (HFD/fasted) SF1-ChR2 mice, normalized to the respective controls.(D) Schematic of whole-field fluorescence recordings in SF1-GCaMP6m mice.(E) Fluorescence changes in SF1-GCaMP6m mice after an electric shock, terminating feeding or approaching food.(F) Averaged 15 s of changes in fluorescence from (E).Data are expressed as mean values ± SEM. (A)--(C) were analyzed by 2-way ANOVA, RM measures, Sidak as well as by fitting graphs to non-linear regression. Symbols denote significance of post hoc tests but were omitted from (C) for visual clarity. 30-s baselines prior to the behaviors were used in (E). 1-way ANOVA was used for treatment effect in (E) and (F). 1-sample t test was used in (F) (^∗^p \< 0.05 and ^∗∗^p \< 0.01). See also [Figure S6](#mmc1){ref-type="supplementary-material"}.

Food Detection Lowers and an Anxiogenic Stimulus Elevates SF1 Activity in Freely Moving Mice {#sec2.8}
--------------------------------------------------------------------------------------------

The preceding experiments suggest that suppressing SF1 activity is permissive for feeding while increasing activity occludes food intake. To directly monitor SF1 neuronal activity during feeding-related and stress-induced behavior, we recorded fluorescence in SF1 neurons expressing a calcium reporter of neuronal activity ([Figure 6](#fig6){ref-type="fig"}D). Food presentation to fasted mice showed that SF1 activity decreased upon approach to food, while leaving food was associated with increased activity ([Figures 6](#fig6){ref-type="fig"}E and 6F). The activity changes were highly specific to food, as approaching or leaving an empty food pot or presentation of a non-edible object had little effect on SF1 activity ([Figures S6](#mmc1){ref-type="supplementary-material"}E--S6G). Furthermore, the stressful experience of a foot shock elicited a marked activation of SF1 neurons that was significantly greater than feeding termination ([Figures 6](#fig6){ref-type="fig"}E and 6F). Therefore, consistent with our optogenetic and chemogenetic studies, feeding behavior was associated with low while anxiety was associated with high intrinsic SF1 activity.

Discussion {#sec3}
==========

Hypothalamic and limbic neuronal populations not only regulate feeding but also control related motivated behaviors and affective states ([@bib35], [@bib36]). VMH neurons also control food intake and other behavioral outputs, and, therefore, they may subserve a similar integrative role, but to date there has been no rigorous attempt to study such an interaction. Here, using systematic behavioral and physiological phenotyping platforms combined with methods to acutely alter or measure neuronal activity, we show that SF1 neurons (the predominant VMH population) alter food intake via changes in appetite and feeding-related behaviors, identifying a key part of the neurocircuitry controlling both ingestive behavior and related affective states.

SF1 Neurons Regulate Acute Food Intake in an Activity-Dependent Manner {#sec3.1}
----------------------------------------------------------------------

We show that optogenetic stimulation of SF1 neurons, at typical steady-state frequencies, acutely inhibits food intake. Likewise, chemogenetic stimulation reduces while chemogenetic suppression of SF1 neurons increases food intake, demonstrating acute regulation of feeding behavior by this neuronal population. Consistent with these induced changes, SF1 activity measured in freely moving mice was lower when they engaged with food and was higher under stressful conditions.

While these findings align with historical studies utilizing electrical stimulation of VMH neurons to inhibit food intake, and with VMH-lesioning studies that were associated with marked hyperphagia, these approaches lack cellular precision and may have stimulated or damaged fibers that traverse the VMH ([@bib20]). Therefore, some of the roles ascribed to the VMH may have been due to effects on cell populations outside the VMH. More recent genetic studies specifically targeting hormone- and nutrient-signaling pathways in VMH SF1 neurons have demonstrated key roles in body weight regulation, but somewhat surprisingly they have not revealed effects on feeding ([@bib8], [@bib10], [@bib12], [@bib19], [@bib21], [@bib28], [@bib39], [@bib40]). In contrast, our data directly establish an inverse relationship between SF1 neuron activity and acute food intake. That such effects are relevant to energy homeostasis is suggested by the changes in adiposity seen with sub-chronic alteration of SF1 activity. There are several explanations for the different outcome on feeding behavior seen when constitutively deleting signaling pathways in the SF1-Cre mice (as opposed to acutely altering SF1 activity), including potential developmental effects, loss of function in extrahypothalamic sites, and changes in gene expression and other elements of neuronal function.

Our optogenetic data reveal a firing frequency-dependent switch from feeding to escape behavior, demonstrating the benefit of detailed phenotyping over a range of optogenetic stimulation frequencies. There are few studies employing a range of optogenetic stimulation frequencies, but these have also shown frequency-dependent phenotypic switches ([@bib4], [@bib5], [@bib38]). Studies to date utilizing optogenetics in SF1 neurons, and indeed AgRP neurons, have utilized stimulation protocols typically around 20 Hz (and often for several hours), not reflecting typical *in vivo* or *in vitro* firing patterns and limiting the ability to reveal behavioral changes caused by minor alterations in steady-state firing.

Our optogenetic data reveal that the switch from feeding to anxiety-related behavior is also sensitive to the energy storage status of mice. Mice with lower adipose tissue mass, therefore, tolerate a higher stimulation frequency before they display avoidance behavior when compared to mice with elevated fat stores. This is consistent with the idea that, in natural environments, mice with lower energy stores may take higher risks to secure food. In terms of potential mechanisms, previous studies have revealed that leptin alters SF1 neuron excitability. Deletion of the leptin receptor in these cells caused mild obesity, but this did not alter food intake, suggesting that leptin signaling per se may not mediate the effects we observed. It is possible that alterations in energy stores change the sensitivity of other nutrient-responsive circuits downstream of SF1 neurons, which in turn mediate nutrient-sensitive avoidance behavior.

SF1 Neurons Regulate Affective States Underlying Both Food Consummatory and Competing Behaviors to Create Activity-Dependent Feeding-Permissive or -Occlusive States {#sec3.2}
--------------------------------------------------------------------------------------------------------------------------------------------------------------------

Homeostatic feeding is driven by hunger and appetite, and it requires integration of visceral and adiposity information regarding energy status. Food consumption, particularly in the wild, is, however, also dependent on the success of acquiring food, which can be reliant on underlying affective states to control the risks taken under various anxiogenic conditions. Therefore, the neurocircuits contributing to the control of nutrient intake, must also incorporate sensory, valence, arousal, motivational intensity, reward, and memory information to regulate a number of related behaviors, including foraging, risk-taking, and dealing with anxiogenic stimuli ([@bib27], [@bib31], [@bib35]). Recent studies have explored this relationship between feeding and other related behaviors. For example, AgRP, lateral hypothalamic, and amygdalar neurons have important roles in the incorporation of associated emotional aspects into the regulation of feeding. Activation of AgRP neurons leads to voracious eating, and their activity has been shown to anticipate food while also establishing emotional states that promote feeding (reviewed in [@bib35]). GABAergic and glutamatergic neurons in the lateral hypothalamus also regulate food intake by controlling rewarding aspects of feeding, while amygdalar neurocircuits have been implicated in control feeding in addition to regulating valence (reviewed in [@bib35]).

SF1 neurons also represent an attractive population for regulating such aspects of feeding behavior, but recent studies using optogenetics and chemogenetics to investigate VMH and SF1 neuron function have mostly focused on specific defensive and fear behavioral outputs and did not analyze food intake. Thus, a male aggression locus has been identified in the ventrolateral subdivision of the VMH (vlVMH), and the activity of neurons in this region impacts on the competing behaviors of inter-male aggression and mating ([@bib23], [@bib24]). Furthermore, optogenetic activation of SF1 neurons, which largely comprise the dorsomedial part of the VMH (dmVMH), drives different defensive behaviors in a range of contexts displaying features consistent with the establishment of a defensive emotional state ([@bib22]). Likewise, separate optogenetic studies have suggested that the activation of different SF1 projections causes distinct defensive behaviors, such as immobility or avoidance ([@bib37]). In addition, chemogenetic inhibition of SF1 neurons has been shown to suppress predator fear while inhibition of vlVMH neurons reduced social fear, suggesting partitioning of these behavioral outputs to different VMH neuronal populations ([@bib29], [@bib30]). A recent study has demonstrated DREADD-mediated activation inhibits food intake, although the effects of suppressing SF1 activity upon feeding and the relationship to related behaviors were not explored ([@bib11]).

We find that food intake elicited by the modulation of SF1 activity may result from both direct alterations in appetite and/or through changes in a range of feeding-permissive related behaviors. High-frequency stimulation of SF1 neurons is associated with states of high arousal, negative valence, and high motivational intensity, and this behavioral state is not consistent with feeding. Likewise, SF1 activity increased markedly under anxiogenic conditions. In contrast, pharmacogenetic and low-frequency optogenetic stimulation results in milder modulation of SF1 neurons and produces more nuanced changes in affective states. For example, we show that the inhibition of SF1 neurons produces increased feeding, specific interest in food, positive valence, and diminished anxiety while increasing locomotion and exploration. Together these conditions could be associated with an increased arousal state and wider cognitive scope and create an emotional state permissive for feeding to occur. On the other hand, low-frequency stimulation of SF1 neurons both suppressed food intake and lowered activity and exploration while increasing anxiety. Together these behaviors create a state that reduces feeding. Consistent with these observations, SF1 neurons showed decreased activity in freely behaving mice engaging with food and increased activity when mice moved away from food.

In tests examining the influence of SF1 neurons on feeding under naturalistic, stressful conditions that may occlude feeding, the inhibition of SF1 neurons created a behavioral state that was also more directed toward food intake. This low SF1 neuron activity, feeding-promoting behavioral state occurred irrespective of the negative stimulus used (e.g., open illuminated area, electric shocks, or innate fear-inducing smell), consistent with the idea that the VMH may regulate affective reactions to all sensory inputs and that these may be responsible for some of the appetitive behaviors ([@bib15]). However, we also observed that SF1-hM4Di mice have specific interest in food above that of non-edible objects, while 2-Hz optogenetically stimulated mice spent less time near the food, suggesting direct or indirect effects of SF1 neurons on appetite. It would thus appear that, most of the time, SF1 neurons are engaged in regulating feeding behavior and affective states that influence this but have the capacity to switch to high-firing frequency-dependent escape and defensive behavior when required, such as when faced by immediate predator threat or fighting with aggressive conspecifics. Our feeding and behavioral data reveal no phenotypic sexual dimorphism, suggesting some segregation in behavioral outputs and perhaps related to distinct neuronal populations (e.g., SF1- and ERα-expressing VMH neurons) being involved. Our data thus demonstrate that SF1 neurons constitute a behavioral gateway for feeding-permissive states, where inhibition of SF1 neurons shifts the balance between feeding and competing motivations toward consummatory behavior.

SF1 Neuron Integrative Function in the Context of Developing Model of Neurocircuits Controlling Feeding and Behavior {#sec3.3}
--------------------------------------------------------------------------------------------------------------------

The SF1 circuitry can be incorporated into the developing model of brain integration of feeding and competing behavioral goals. VMH neurons directly synapse onto anorectic POMC neurons in a nutrient-sensitive manner ([@bib33]), providing a potential link between SF1 neurons and the melanocortin system, a key regulator of feeding and energy homeostasis. While not directly linked with AgRP neurons, SF1 neurons also share common projection sites with AgRP neurons, which presents an additional point of intersection between these systems ([@bib6], [@bib9]). Given that multiple hypothalamic neuronal populations may control both food intake and various associated behaviors, it is possible that there may be the potential for context-specific regulation of feeding depending on behavioral circumstances. Interestingly, sensory detection of food is associated with a reduction in AgRP neuron activity, akin to our findings in SF1 neurons when mice approach food. Interactions between these populations could thus constitute a key part of the neurocircuitry for behavioral selection between the competing motivations for food and safety, and future studies will be key for dissecting the precise relationships and hierarchy.

SF1 Neuron Function in the Context of Human Feeding and Anxiety {#sec3.4}
---------------------------------------------------------------

In the wild, feeding is a necessary set of actions required to procure nutrients and energy, but at the same time animals are often at their most vulnerable. Although in today's world food is easily accessible to most humans, our ancestors were frequently in danger from environmental factors, rivals, and predators when they ventured out from the safety of their dwellings to eat. Therefore, the regulatory systems have evolved to fine-tune and incorporate energy metabolism with emotional states and their behavioral outputs. These neurocircuits and signaling pathways that were necessary for survival have significant functional overlap, are complex and redundant, and are highly conserved to present-day humans ([@bib25], [@bib35], [@bib36]). Therefore, in humans, mutations or defects in neural pathways causing obesity or metabolic disorders have a significant association with emotion-related disorders, such as anxiety and depression ([@bib1], [@bib13], [@bib14], [@bib16], [@bib34]). Importantly, while both metabolic disease such as obesity and emotional disorders are very common, there are few therapies that specifically target such diseases in part due to the common neuronal mechanisms regulating such processes. Thus, many drugs used to treat psychiatric disorders are associated with unwanted metabolic side effects, and many agents previously used to treat obesity displayed undesirable behavioral and psychological effects that have led to their withdrawal as treatments. Given the findings presented in this study, SF1 neurons are identified as an important part of the neurocircuitry regulating feeding and affective states, and, therefore, they may underpin some of these side effects and yet also provide new therapeutic opportunities for treating metabolic or emotional disorders.

Experimental Procedures {#sec4}
=======================

Statistical Analysis and Data Reporting {#sec4.1}
---------------------------------------

Statistical comparisons were performed using parametric (un-)paired t tests or 1-way ANOVA, followed by a Sidak post hoc for single time-point data. 2-way ANOVA with repeated-measures (RM) and Sidak test or non-linear fitting was used for time course experiments. The precise statistical tests used are indicated in the figure legends, while F and p values, degrees of freedom, and sample size (n) are shown in the figures. Data are expressed as mean values ± SEM. Where significance is presented, p values are as follows: ^∗^p \< 0.05, ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.001, and ^∗∗∗∗^p \< 0.0001.

Experiment Design {#sec4.2}
-----------------

Male and female mice were used for most experiments, except for optogenetic experiments that used males only. For studies requiring surgery, adult mice aged 8--12 weeks old were used, and at least 3 weeks were allowed for recovery and virus expression before the start of the experiments. Power calculations for the number of animals required for every experiment were based on reported or known effect sizes and variation, in order to maximize chances of meaningful results without the unnecessary use of the experimental animals. Subject assignment to experimental groups was semi-random, and persons performing experiments, video tracking, scoring, and initial analysis were blinded to this and/or the treatment type where possible. Key physiology and behavior experiments were independently repeated. Raw data were collected in Excel and exported for statistical analyses to GraphPad Prism 6.0.

Animal Use Approval, Genetics, and Husbandry {#sec4.3}
--------------------------------------------

All of the animal procedures conformed to the UK Animals (Scientific Procedures) Act 1986 as well as being approved by our institutional ethical review committee and by the UK Home Office. Findings and experiments described in this paper were designed and reported following the Animal Research: Reporting of *In Vivo* Experiments (ARRIVE) guidelines of animal experiment reporting ([@bib17]). The mouse line expressing Cre recombinase under *Nr5a1*-regulatory elements, referred to as SF1-Cre ([@bib12]), was purchased from the Jackson Laboratory (012462) and backcrossed into C57BL/6 background for 4 generations. The Z/EG line was kindly donated by Dr. C. Lobe ([@bib26]). Animals were housed in specific pathogen-free barrier facilities and maintained under a controlled environment (temperature 21°C--23°C, 12-hr light-dark cycle, lights on at 7:00 a.m.) with *ad libitum* access to food (RM3 chow diet, Special Diet Services) and water, unless stated otherwise. Animals were group-housed with up to 5 mice per cage for experimental studies, unless otherwise required and explicitly stated, e.g., for food intake studies, where mice were singly housed. Please see the [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"} for details on genotyping.

Generation of Viral Vectors {#sec4.4}
---------------------------

Viruses used in this project included AAV1-Ef1a-DIO-hM3Dq-mCherry, AAV1-Ef1a-DIO-hM4Di-mCherry, AAV1-Ef1a-DIO-ChR2-mCherry, AAV1-Ef1a-DIO-EYFP, and AAV1-Syn-Flex-GCaMP6m-WPRE-SV40. The hM3Dq-mCherry coding sequence was cloned by Dr. A.I. Choudhury and Professor G. Milligan; the hM4Di sequence was commercially synthesized (GeneArt, Thermo Fisher Scientific), according to published data ([@bib3]), and inserted into pAAV-EF1a-DIO-WPRE vectors instead of ChR2, which was gifted by Professor K. Deisseroth. Ef1a-DIO-EYFP was purchased from Addgene (Plasmid 27056, deposited by Professor K. Deisseroth) and commercially packaged in AAV serotype 2/1 vector consisting of the AAV2 ITR genomes and the AAV1 serotype capsid gene in Penn Vector Core, University of Pennsylvania. AAV1.Syn.Flex.GCaMP6m.WPRE.SV40 was purchased from Penn Vector Core (AV-1-PV2820). All other vectors were commercially packaged in the same manner in Vector Biolab, Philadelphia. All of the viruses below the titer of 1.2 × 10^13^ were used directly, while the titers above this were diluted in sterile PBS A, 5% glycerol (pH 7.2) down to 1.2 × 10^13^ genome copies.

Stereotaxic Surgery Procedure {#sec4.5}
-----------------------------

Viruses used were stereotaxically targeted to the VMH (anteroposterior \[AP\], −1.35; mediolateral \[ML\], ± 0.45; dorsoventral \[DV\], −5.70). For optogenetic studies, custom-made optic fiber cannulae (200-μm diameter, 0.39-numerical aperture (NA) fiber with 1.25-mm ceramic ferrule; Thorlabs) were implanted at a 10-degree angle bilaterally above the VMH (AP, −1.35; ML, ± 1.50; DV, −5.10), of mice that had been previously injected with the AAV1-ChR2 in the same procedure. For Ca^2+^ imaging, a ProView gradient index (GRIN) lens (0.6-mm diameter, 7.3-mm length; Inscopix) was implanted ∼200 μm above the VMH of AAV1-GCaMP6m-injected animals.

Optogenetic Stimulation Setup {#sec4.6}
-----------------------------

Laser light sources used were ×1 473 nm, 50 mW (CL-473-050, CrystaLaser) and ×3 473 nm, 80 mW (STRADUS-473-80, Laser 2000). Light intensity of CrystaLaser devices was regulated mechanically, whereas light intensity of Stradus lasers was controlled by Vortran PC software. Laser activity patterns were transistor-transistor logic (TTL) governed by MC_Stimulus II software and two stimulus generators from Multichannel Systems (STG4004 and STG4008). Laser sources were connected to beam-splitting, collimated rotary joints (FRJ_1x2i_FC-2FC_0.22, Doric Lenses) via optic cables (diameter of 200 μm, 0.39 NA, M72L02; Thorlabs). The divided beam was fed into custom-length patch cords (fiber connector/physical connection \[FC/PC\] to 1.25-mm ceramic ferrule patch cord; Thorlabs) that was connected to the fiber implants on the animals via mating sleeves (1.25-mm diameter mating sleeve; Thorlabs).

Behavior Analysis {#sec4.7}
-----------------

For DREADD studies, CNO (Key Organics) was administered via intraperitoneal (i.p.) injection 30 min prior to the assays (0.5 mg/kg for SF1-hM3Dq and 2.5 mg/kg for SF1-hM4Di animals) or in the drinking water at 50 mg/L. For optogenetic studies, 5-mW (2.8--1.0 mW/mm^2^ in the VMH), 488-nm, 1-ms laser light stimulation was used ([@bib2], [@bib41]). Animal behavior was filmed, video-tracked, and subsequently analyzed by the EthoVision XT (Noldus) software. Please see the [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"} for more detail.

Prolonged Optogenetic Stimulation and Autonomic Function Assessment {#sec4.8}
-------------------------------------------------------------------

Behavioral effects of long-term optogenetic stimulation were evaluated by continuously stimulating animals for 1 hr in a square open field at 2- or 5-Hz frequency and by 5-hr-long 2-Hz stimulation of mice in a home cage environment. Heart rate was measured after 2 hr of stimulation using ECGenie (Mouse Specifics), while the effects of optogenetic stimulation on brown adipose tissue temperature was measured using surgically implanted transponders (IPTT-300, Plexx).

*In Vivo* Ca^2+^ Dynamics {#sec4.9}
-------------------------

A miniature head-mounted camera (nVista, Inscopix) was used to perform microendoscopic imaging of Ca^2+^ dynamics in freely behaving, GRIN lens-implanted SF1-GCaMP6m animals. The effects of food were analyzed by placing overnight-fasted animals in a 2-chamber arena with empty pots in the opposite corners. After 10 min of exploration, food and a non-edible object were placed in the different pots for an additional 20 min. To enable accurate behavioral correlation with neuronal activity, freely behaving animals were tracked with Ethovision XT software. When a specific behavior was detected (e.g., entrance into the feeding zone), TTL signals were sent via an external module into the data acquisition (DAQ) box, and timestamps were subsequently recorded in the nVista acquisition software. Electric shocks (0.4 mA) in the fear-conditioning box (Med Associates) were given at predefined times. Data were processed using Mosaic software (Inscopix) and analyzed in Excel. 30 s of recording before the onset of behavior/shock was used as a baseline for the calculations of the change in fluorescence for every time point.

*Ex Vivo* Electrophysiology {#sec4.10}
---------------------------

Slice electrophysiology was performed essentially as previously described ([@bib32]). In brief, brains of SF1-Cre transgenic mice transfected with EYFP, hM3Dq, hM4Di, or ChR2 virus were rapidly transferred to an ice-cold slicing solution containing 2.5 mM KCl, 1.25 mM NaH~2~PO~4~, 28 mM NaHCO~3~, 0.5 mM CaCl~2~, 7 mM MgCl~2~, 7 mM D-glucose, and 235 mM sucrose, and they were equilibrated with 95% O~2~ 5% CO~2~ to give a pH of 7.4. The 350-μm coronal brain slices were prepared using a Vibratome Series 1000. Slices containing the VMH were kept at room temperature in a normal external solution, containing 125 mM NaCl, 2.5 mM KCl, 1.25 mM NaH~2~P~4~, 25 mM NaHCO~3~, 2 mM CaCl~2~, 1 mM MgCl~2~, 10 mM D-glucose, 15 mM D-mannitol, equilibrated with 95% O~2~ 5% CO~2~ (pH 7.4). For whole-cell recordings, slices were continuously perfused with normal external solution at a rate of 5--10 mL/min. Neurons were identified using epifluorescence and differential interference contrast optics, using an upright Slicescope (Scientifica) microscope. Borosilicate patch pipettes (5--8 MΩ) were filled with an internal solution containing 130 mM potassium gluconate, 10 mM KCl, 0.5 mM EGTA, 10 mM HEPES, 1 mM NaCl, 0.28 mM CaCl~2~, 3 mM MgCl~2~, 3 mM KATP, 0.3 mM Tris-GTP, and 14 mM phosphocreatine (pH 7.2). Data were digitally recorded and stored for offline analysis. We examined changes in input resistance by monitoring membrane potential responses to tonic-negative, rectangular current pulses (5--20 pA, 200 ms, 0.05 Hz) or by current-voltage relations (−80 to +30 pA, 200 ms) injected via the recording electrode. Application of drugs or CNO was made via the bath perfusion system at the concentrations indicated.

*In Vivo* Electrophysiology {#sec4.11}
---------------------------

Mice were anesthetized with isoflurane in an induction chamber. The animal was then i.p. injected with urethane (Ethyl carbamate, 25% w/v, dose of 1.5 g/kg) and glycopyrrolate (0.01 mg/kg) and placed into a stereotaxic frame. It was monitored for 20 min to judge the depth of anesthesia (breathing rate and pinch reflex). Anesthesia was topped up if required by 10% of the initial dose, but with at least 20-min periods of rest. Bupivacaine (2.5 mg/mL) was administered locally prior to the surgery. The animal was kept warm with an insulation cover, and core body temperature was monitored with a thermometer probe. The skin over the skull was removed and the skull was cleaned with saline. A craniotomy was performed above the VMH by drilling a rectangle in the skull and lifting the bone with tweezers. 0.45% saline was used to wash the surface of the brain. The electric circuit was grounded into the neck muscle posterior of the skull. A glass microelectrode, with a tip diameter of 1--1.5 μm, resistance of 15--25 MΩ, and filled with 1.5% neurobiotin in 0.5 M NaCl, was slowly lowered (1--10 μm/min) into the brain toward the target area.

Coordinates used for recordings in the VMH were as follows: AP, −1.3 to −1.6; DV, −5.25 to −5.75; and ML, ± 0.45 mm. When the electrode reached the target area, the movement speed was decreased. Recording began when a clearly isolated single unit was detected. Neuronal activity was typically measured for at least 10 min before the animal was i.p. injected with CNO (doses used for *in vivo* experiments: 0.5 mg/kg for hM3Dq and 2.5 mg/kg for hM4Di). In some recordings, an additional high dose (50 mg/kg) of CNO was injected to confirm the responsiveness of the recorded neurons. Recordings were AC-coupled, amplified (×1,000), filtered (0.3--5 kHz), and acquired with Spike 2 software on a PC. For statistical analysis, action potential events were assigned into 20-s bins. Periods of 5 min before and 15 min after CNO injection were compared statistically. Mean firing frequency was calculated as an average frequency over the 5-min periods. Peak firing frequency was the frequency of a 20-s bin with the highest firing frequency during the 5-min analysis period. After the recording, some neurons were selectively labeled by the juxtacellular technique with biotin that involved positive current-pulse application through the microelectrode (200 ms, 2.5 Hz, 1--5 nA). Changes in the frequency were normalized between neurons using *Z* scores, where the population mean and SD were estimated from the initial 5 min of recording.
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